Driving the Best Science to Meet Global Health Challenge s


Download 23.86 Kb.

bet6/31
Sana09.02.2017
Hajmi23.86 Kb.
1   2   3   4   5   6   7   8   9   ...   31

 
in teaching networks?
B . Peterhans, P . Grys, N . Casamitjana, L . Gerstel (Basel, CH; 
Heidelberg, DE; Barcelona, ES; Amsterdam, NL) 
O.4.6.2.004 
APARET (African Programme for Advanced Research 
14 .15
 
Epidemiology Training)
N .G . Schwarz, S . Gitta, A . Briet, E . Rutebemberwa (Hamburg, 
DE; Kampala, UG; Basel, CH) 
O.4.6.2.005 
A public health laboratory for global capacity building in
14 .30
 
sub-Saharan Africa
S .M . Ali, S .M . Ame, Y .M . Al-Sawafi, A . Carozzi, M . Albonico, 
M .S . Jiddawi, J . Tahib, L . Savioli (Pemba, Zanzibar, TZ;  
Milan, IT) 
13 .30 – 15 .00
 
Parallel Session 3.2.4. 
Kairo 2
 
(Disease systems) 
 
Visceral leishmaniasis – from patient to public health 
needs: the role of R&D in disease elimination and 
control 
 
Convener and Chair: Susan Wells (Geneva, CH)  
 
Chair: Jose Antonio Ruiz Postigo (Geneva, CH) 
13 .30
 Introduction 
INV.3.2.4.001 
Treatment of visceral leishmaniasis
13 .35
 
S . Sundar (Varanasi, IN) 
INV.3.2.4.002 
Translating treatment options to control programs
13 .50
 
Margriet den Boer (Amsterdam, NL) 
INV.3.2.4.003 
Developing new treatments to address unmet medical needs
14 .10
 
Jorge Alvar (Geneva, CH) 
INV.3.2.4.004 
Opportunities in visceral leishmaniasis: analysis of large, 
14 .30
 
pooled data sets
P .J . Guerin (Oxford, GB) 
14 .50
 Discussion 

34
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
13 .30 – 15 .00
 
Parallel Session 5.2.1. 
Samarkand
 
(From research to implementation) 
 
How to bridge between health systems researchers 
and practitioners in the field of international health 
cooperation 
 
Convener and Chair: Thomas Schwarz (Basel, CH) 
O.5.2.1.001 
Challenges and solutions in collaboration between 
13 .30
 
non-governmental implementing organizations and local 
research institutions in developing countries
J . Perkins, C . Capello, C . Santarelli (Geneva, CH) 
O.5.2.1.002 
Key determinants for a successful collaboration between
13 .45
 
NGOs and universities in health research
M .A . Hobbins, M . Bryant, T . Miwa, C .S . Masengu, J . Balen, 
A . Häggblom, J . Ehmer (Lucerne, CH; Sheffield, GB) 
O.5.2.1.003 
From well-researched, tested and documented pilot inter-
14 .00
 
ventions to health impact for all; from laboratory systems 
research to changing lives: in search of the holy grail of 
scalability
B . Vander Plaetse (Basel, CH) 
O.5.2.1.004 
Improving programme implementation through embedded 
14 .15
 
implementation research (iPIER)
N .T . Tran (Geneva, CH) 
O.5.2.1.005 
Fairness in international collaborative research partner-
14 .30
 
ships for health, time for a certification process: COHRED 
Fairness Index
J .K . Lazdins, N . Musolino, C . IJsselmuiden, J . Toohey  
(Geneva, CH) 
O.5.2.1.006 
Successfully connecting NGO practice and health systems
14 .45
 
research – getting evidence into NGO practice & NGO 
practice into research 
N . Moran (Konstanz, DE) 
15 .00 – 15 .30
 
Emergency evaluation of convalescent  
Sydney
 
plasma – a film on the Ebola-Tx trial in 
 
Conakry, Ghana

35
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
15 .30 – 17 .00
 
Parallel Session 5.6.6. 
San Francisco 
 
(From research to implementation) 
 
Implementation research – key to effectiveness 
 
Convener and Chair: Pascal Launois (Geneva, CH)  
 
Chair: Edward Kamau (Geneva, CH) 
15 .30
 Introductions 
INV.5.6.6.001 
Opening remarks from Director TDR
15 .35
 
John Reeder (Geneva, CH) 
INV.5.6.6.002 
Research capacity strengthening and knowledge manage-
15 .45
 
ment for health teams towards improvement in disease 
control in Ghana (Ghana RCS4FIVE)
E .K . Ansah, A . Ofosu, M .A . Chinbuah, B . Garshong, 
M . Gyapong (Accra, GH) 
INV.5.6.6.003 
Effectiveness of short term training on health economics 
15 .55
 
in improving knowledge and economic way of thinking to 
help break vicious cycle of infectious disease and poverty: 
an evidence from Nepal
S . Raj Adhikari (Kathmandu, NP) 
INV.5.6.6.004 
Estimating of the level of insecticide availability in some
16 .05
 
samples of sprayed surfaces (IRS) using insecticide 
quantification kits (IQK) in Benin
L .S . Djogbenou, H . Degnovi, M . Paine, M . Makoutode 
(Ouidah, BJ; Liverpool, GB) 
INV.5.6.6.005 
The new 1,3,7 strategy and implementation for malaria 
16 .15
 
elimination in China
G . Qi (Wuxi, Jiangsu, CN) 
INV.5.6.6.006 
Implementation of a mentorship programme on knowledge
16 .25
 
translation/management to improve policymakers‘ 
capacity for evidence-informed policymaking for the 
control of infectious diseases of poverty in Nigeria
C .J . Uneke, A .E . Ezeoha, H .C . Uro-Chukwu, C .T . Ezeonu 
(Abakaliki, NG) 
INV.5.6.6.007 
Implementation research dashboard tool for district health
16 .35
 management
O .R . Mukasa, A .Z . Swai, I . Lyatuu, C . Mumburi  
(Dar es Salaam, TZ) 
16 .45
 
Questions and discussion moderated by the Chair 

36
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
15 .30 – 17 .00
 
Parallel Session 3.2.10. 
Sydney
 
(Disease systems) 
 
Ebola – vaccination 
 
Convener and Chair: Marcel Tanner (Basel, CH) 
INV.3.2.10.001 
Phase I testing of the ebola VSV-ZEBOV candidate vaccine:
15 .30
 
the Geneva files
Angela Huttner (Geneva, CH) 
INV.3.2.10.002 
Safety and immunogenicity of the Chimpanzee-Adenovirus
16 .00
 
vectored Ebola vaccine: the Lausanne phase I/IIa clinical 
trial
O . De Santis, R . Audran, E . Pothin, L . Warpelin-Decrausaz, 
L . Vallotton, G . Wuerzner, C . Cochet, D . Estoppey, V . Steiner-
Monard, S . Lonchampt, A .-C . Thierry, C . Mayor, R .T . Bailer, 
O . Tshiani Mbaya, Y . Zhou, A . Ploquin, N .J . Sullivan, 
B .S . Graham, F . Roman, I . De Ryck, R . Ballou, M .P . Kieny, 
V . Moorthy, F . Spertini, B . Genton (Basel, Geneva, Lausanne, 
CH; Bethesda, US; Rixensart, BE) 
O.3.2.10.003.LB 
Malaria prevalence decreased following mass drug 
16 .30
 
administration of malaria chemoprevention during the 
Ebola outbreak, Monrovia, Liberia, 2014
A . Kuehne, A . Tiffany, K . Danis, M . Janssens, E . Lasry, 
C . Okonta, C . Besse, V .S . Koko, A . Pah, K . Larbi, K . Porten 
(Berlin, DE; Stockholm, SE; Paris, FR; Geneva, CH; Monrovia, 
LR; New York, US) 
INV.3.2.10.004 
Testing new therapeutics while handling a crisis: ethical 
16 .45
 
and medical considerations
Graeme Bilbe (Geneva, CH)

37
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
15 .30 – 17 .00
 
Parallel Session 3.5.3.  
Singapore
 
(Disease systems) 
 
Women and immunization, life-saving vaccines to 
protect women’s and infant’s health 
 
Convener and Chair: Clara Menendez (Barcelona, ES)  
 
Chair: Azucena Bardají (Barcelona, ES) 
INV.3.5.3.001 
Introduction of the HPV vaccination in African 
15 .30
 
pre-adolescents: lessons learnt from Mozambique
Khatia Munguambe (Vila de Manhiça, MZ) 
INV.3.5.3.002 
Influenza vaccination of pregnant women and protection 
15 .45
 
of their infants
Mark Steinhoff (Cincinnati, US) 
INV.3.5.3.003 
Trivalent vaccine in pregnant women to prevent perinatal 
16 .00
 
Group B Streptococcus infection
Rino Rappuoli (Siena, IT) 
INV.3.5.3.004 
Maternal immunization against pertussis, protecting 
16 .15
 
mothers and infants in early life
Scott A . Halperin (Halifax, CA) 
INV.3.5.3.005 
Leadership in promoting protection of pregnant women 
16 .30
 
and their infants by maternal immunization
Ajoke Sobanjo-ter Meulen (Seattle, US) 
INV.3.5.3.006 
Open discussion and way forward: contributing to the 
16 .45
 
global research agenda on women’s and maternal health
Clara Menendez (Barcelona, ES)  
Azucena Bardají (Barcelona, ES) 

38
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
15 .30 – 17 .00
 
Parallel Session 3.1.3.  
Montreal
 
(Disease systems) 
 
Malaria elimination: getting there and staying there 
 
 Convener and Chair: Regina Rabinovich (Barcelona, ES; 
Boston, US) 
INV.3.1.3.001 
Prevention of reintroduction of Malaria
15 .30
 
Majed Zedjali (Muscat, OM) 
INV.3.1.3.002 
Entomological surveillance system to inform the 
15 .45
 
elimination strategy
Krijn Paaijmans (Barcelona, ES) 
INV.3.1.3.003 
Ivermectin for malaria vector control, prospects and 
16 .00
 challenges
C . Chaccour (Barcelona, Pamplona, ES) 
INV.3.1.3.004 
What we’re learning about mass drug administration 
16 .15
 
in Zambia
Duncan Earle (Lusaka, ZM) 
O.3.1.3.005.LB 
Decline in the burden of malaria in pregnancy in Southern
16 .30
 
Mozambique: evidence from a 14-year period and 
implications for malaria elimination
R . Gonzalez, A . Bardaji, E . Sevene, F . Saute, M . Rupérez, 
S . Maculuve, C . Guinovart, A . Valá, R . Aguilar, J . Aponte, 
E . Macete, P .L . Alonso, C . Menendez, A . Mayor (Barcelona, ES; 
Manhiça, MZ) 

39
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
15 .30 – 17 .00
 
Parallel Session 4.2.1. 
Delhi 
 
(Health and social systems)
 
Improving access to essential quality health services 
 
Convener and Chair: Christian Lengeler (Basel, CH) 
INV.4.2.1.001 
Improving access to healthcare – a critical element for 
15 .30
 
advancing universal health coverage in Sub-Saharan Africa
F .L . Kessy (Dar es Salaam, TZ) 
O.4.2.1.002 
Identifying and addressing structural quality gaps in 
16 .00
 
primary health care in Tanzania 
D .M . Mboya, F .L . Kessy, C .E . Mshana, A . Schulze, C . Lengeler, 
B . Vander Plaetse (Dar es Salaam, Ifakara, TZ; Basel, Berne, CH) 
O.4.2.1.003 
Heterogeneity of fever case management and provider 
16 .15
 
performance at private clinics and pharmacies on the 
Kenyan coast: results from client exit and mystery client 
studies and competency assessments
S . Poyer, P . Njagi, J . Makoyo, R . Ochako, C . Lussiana, N . Njoki, 
S . Dolan, N . Charman (Nairobi, KE) 
O.4.2.1.004 
Official invitation letters are highly effective to increase 
16 .30
 
male partner participation in antenatal care services in 
Mbeya Region, Tanzania
L . Jefferys, P . Nchimbi, P . Mbezi, J . Sewangi, S . Theuring 
(Berlin, DE; Mbeya, TZ) 
O.4.2.1.005 
The One-Stop Clinic of Ifakara: a model for integration of 
16 .45
 
prevention of mother-to-child transmission and pediatric 
HIV services
A . Gamell, L .B . Luwanda, T .R . Glass, D . Mpundunga, A . Chale, 
L . Samson, L . Muri, A . Ntamatungiro, C . Hatz, M . Tanner, 
E . Letang, M . Battegay (Basel, CH; Ifakara, TZ; Barcelona, ES) 

40
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
15 .30 – 17 .00
 
Parallel Session 4.2.3. 
Boston 1
 
(Health and social systems) 
 
Health workers patients interactions – key to 
compliance and adherence 
 
Convener and Chair: Sharon Fonn (Johannesburg, ZA) 
O.4.2.3.002 
The human factor in the clinical management of infectious
15 .30
 
diseases of poverty in remote, low-resource settings. 
A discussion of four qualitative studies on healthcare 
provider attitudes and practices
D . Hendrickx, R . Walker, J . Carapetis, M . Boelaert (Perth, AU; 
Antwerp, BE) 
O.4.2.3.003 
Quality improvement of antenatal and intrapartum care 
15 .45
 
services in Southern Tanzania: the health care workers‘ 
perspective
J . Jaribu, S . Penfold, F . Manzi, J . Schellenberg, C . Pfeiffer 
(Basel, CH; Dar es Salaam, TZ; London, GB) 
O.4.2.3.004 
Knowledge about Chagas disease of patients and health 
16 .00
 
professionals in a non-endemic areas: are there differences?
I . Claveria, J . Caro, H . Ouaarab, B . Treviño, N . Serre, D . Pou, 
A . Soriano, R .M . Morales, J . Gómez i Prat (Barcelona, ES) 
O.4.2.3.005 
An operational comparative study of quinine and 
16 .15
 
artesunate for the treatment of severe malaria in hospitals 
and health centres in The Democratic Republic of Congo: 
the MATIAS study
G . Ferrari, H . Maggi Ntuku, C . Burri, A . Tshefu Kitoto, 
S . Duparc, P . Hugo, D . Kalemwa Mitembo, A . Ross, 
P .L . Ngwala, N . Luwawu, P .N . Musafiri, S . E . Ngoie, C . Lengeler 
(Basel, Geneva, CH; Kimpese, Kinshasa, Kisantu, Maluku, CD) 

41
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
15 .30 – 17 .00
 
Parallel Session 3.2.5. 
Boston 2
 
(Disease systems) 
 
Diagnosis and management of cutaneous 
 leishmaniasis in travellers 
 
Convener and Chair: Johannes Blum (Basel, CH) 
INV.3.2.5.001 
Harmonization of molecular diagnosis for Leishmania 
15 .30
 
species-specific treatment
Ingrid Felger (Basel, CH) 
INV.3.2.5.002 
Comparison of Leishmania species typing results in 
15 .50
 
17 European clinical laboratories
G . Van der Auwera, A . Bart, C . Chicharro, S . Cortes, 
L . Davidsson, T . Di Muccio, I . Felger, M . Grazia Paglia, 
F . Grimm, G . Harms, C .L . Jaffe, T . Kortbeek, I . Maes, 
M . Manser, C . Ravel, F . Robert-Gangneux, S . Töz, J .J . Verweij, 
P . Chiodini (Antwerp, BE; Amsterdam, Bilthoven, Tilburg, 
NL; Madrid, ES; Lisbon, PT; Stockholm, SE; Rome, IT; Basel, 
Zurich, CH; Berlin, DE; Jerusalem, IL; London, GB; Montpellier
Rennes, FR; Izmir, TR) 
INV.3.2.5.003 
Worldwide diversity of leishmaniasis: harmonized 
16 .10
 
collection of data and isolates by the European  
“LeishMan” network
B . Henry, G . Morizot, J . Blum, G . Van der Auwera, J . Clerinx, 
G . Harms, A . Bart, M . Armstrong, C . Ravel, F . Robert-
Gangneux, J .-P . Gangneux, I . Felger, M . Bailey, M . Grögl, 
D . Lockwood, P . Buffet (Montpellier, Paris, Rennes, FR; Basel, 
CH; Antwerp, BE; Berlin, DE; Amsterdam, NL; Birmingham, 
London, GB; Silver Spring, US) 
INV.3.2.5.004 
Visceral leishmaniasis in London- identifying immuno-
16 .30
 
suppression as a risk factor
D . Lockwood, K . Fletcher, R . Issa (London, GB) 
INV.3.2.5.005 
Recommendations for management for cutaneous and 
16 .50
 
mucosal leishmaniasis: case studies and discussion
J . Blum (Basel, CH) 

42
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
15 .30 – 17 .00
 
Parallel Session 3.2.7. 
Shanghai 1
 
(Disease systems) 
 
Geospatial health 
 
Convener and Chair: Jürg Utzinger (Basel, CH) 
INV.3.2.7.001 
A new age in epidemiology – a thermodynamic paradigm
15 .30
 
for studying disease vector’s habitats & life cycles using 
NASA’s remote sensing data
Jeffrey C . Luvall (Huntsville, US) 
O.3.2.7.002 
Malaria incidence and temperature show a steady and 
16 .00
 
correlated increase between 2003 till 2014 in Lubumbashi, 
Democratic Republic of Congo: a spatio-temporal analysis
E .M . Sompwe, E . Hasker, M . Kasombe, O . Luboya, 
A . Mapatano, P . Lutumba, J .-P . Van Geertruyden (Antwerp, BE; 
Kinshasa, Lubumbashi, CD) 
O.3.2.7.003 
A fine-scale geospatial analysis of factors associated with 
16 .15
 
monkeypox transmission, Tshuapa District, Democratic 
Republic of the Congo, 2013
B .P . Monroe, A . Mccollum, J . Doty, L . Osadebee, L . Nolen, 
J . Kabamba, E . Okitolonga, M . Reynolds (Atlanta, US; 
Kinshasa, CD) 
O.3.2.7.004 
Bayesian risk profiling and model-based prediction of 
16 .30
 
soil-transmitted helminth infections among schoolchildren 
from Côte d’Ivoire
R .B . Yapi, F . Chammartin, C .A . Houngbedji, E . Hürlimann, 
P .B . N‘Dri, D .K . Silué, E .K . N‘Goran, J . Utzinger, P . Vounatsou, 
G . Raso (Abidjan, CI; Basel, CH) 
O.3.2.7.005 
Mapping and modelling the geographical distribution and 
16 .45
 
environmental limits of podoconiosis in Ethiopia
K . Deribe, J . Cano, M .J . Newport, N . Golding, R .L . Pullan, 
H . Sime, A . Gebretsadik, A . Assefa, A . Kebede, A . Hailu, 
M .P . Rebollo, O . Shafi, M .J . Bockarie, A . Aseffa, S .I . Hay, 
R . Reithinger, F . Enquselassie, G . Davey, S .J . Brooker (Brighton, 
Liverpool, London, Oxford, GB; Addis Ababa, ET; Bethesda, 
Seattle, Washington, US) 
15 .30 – 16 .30
 
Tropical Medicine & International 
Shanghai 2
 
Health (TMIH) Workshop 2: 
 
Storytelling for scientists: the drama of biomedical 
research papers 
Organizer: Susanne Groener (London, GB) 

43
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
15 .30 – 17 .00
 
Parallel Session 3.5.1. 
Kairo 1
 
(Disease systems) 
 
Research priorities in obstetrics and reproductive 
health 
 
Convener and Chair: Shally Awasthi (Lucknow, IN) 
INV.3.5.1.001 
Research priorities for implementation and generation 
15 .30
 
of evidence in obstetrics and reproductive health for 
countries in need
Suneeta Mittal (New Delhi, IN) 
O.3.5.1.002 
Addressing hidden barriers to institutional deliveries – 
16 .00
 
a key intervention for reducing maternal mortality in rural 
Zambia
V .M . Mukonka, F .M . McAuliffe, S . Malumo, C . Sialubanje, 
P . Fitzpatrick (Lusaka, Monze, Ndola, ZM; Dublin, IE) 
O.3.5.1.003 
Related factors of inter-community of women with 
16 .15
 
gestational diabetes in postpartum diabetes screening 
S .F . Vasegh Rahimparvar, L . Rashidi (Tehran, IR) 
O.3.5.1.004 
A national programme of freely-available ambulance 
16 .30
 
transportation for women in labour halves maternal 
mortality in Ethiopia: an operational analysis from Tigray 
Region
H . Godefay, J . Kinsman, K . Admasu, P . Byass (Addis Ababa, 
Mekelle, ET; Umeå, SE; Johannesburg, ZA) 
O.3.5.1.005 
Maternal body mass index and adverse pregnancy 
16 .45
 
outcomes: a Ghanaian cohort study
E .L . van der Linden, J .L . Browne, K .M . Vissers, E . Antwi, 
I .A . Agyepong, D .E . Grobbee, K . Klipstein-Grobusch (Ede, 
Utrecht, NL; Accra, Greater Accra Region, GH; Johannesburg, 
ZA) 

44
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
15 .30 – 17 .00
 
Parallel Session 4.5.4. 
Kairo 2
 
(Health and social systems)
 
Arthropode-borne diseases 
 
Convener and Chair: Jose Muñoz (Barcelona, ES) 
O.4.5.4.001 
Seasonality of dengue epidemic potential in Europe – 
15 .30
 
based on vectorial capacity for Aedes mosquitoes
J .L . Helmersson, M . Quam, H . Stenlund, A . Wilder-Smith, 
K . Ebi, E . Massad, J . Rocklov (Umea, SE; Singapore, SG; 
Seattle, US; Sao Paulo, BR) 

Do'stlaringiz bilan baham:
1   2   3   4   5   6   7   8   9   ...   31


Ma'lumotlar bazasi mualliflik huquqi bilan himoyalangan ©fayllar.org 2017
ma'muriyatiga murojaat qiling